JP4184785B2 - 抗ヒスタミン薬及び抗アレルギー薬としてのインドリルピペリジン誘導体 - Google Patents

抗ヒスタミン薬及び抗アレルギー薬としてのインドリルピペリジン誘導体 Download PDF

Info

Publication number
JP4184785B2
JP4184785B2 JP2002539348A JP2002539348A JP4184785B2 JP 4184785 B2 JP4184785 B2 JP 4184785B2 JP 2002539348 A JP2002539348 A JP 2002539348A JP 2002539348 A JP2002539348 A JP 2002539348A JP 4184785 B2 JP4184785 B2 JP 4184785B2
Authority
JP
Japan
Prior art keywords
ylmethyl
piperidin
indol
mmol
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002539348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004513127A5 (US07816364-20101019-C00082.png
JP2004513127A (ja
Inventor
ポウ,シルビア フォンケルナ
サンタカナ,リュイス パヘス
ドゥラン,カルレス プイグ
プエヨ,リディア ソカ
Original Assignee
アルミラル プロデスファルマ ソシエダ アノニマ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルミラル プロデスファルマ ソシエダ アノニマ filed Critical アルミラル プロデスファルマ ソシエダ アノニマ
Publication of JP2004513127A publication Critical patent/JP2004513127A/ja
Publication of JP2004513127A5 publication Critical patent/JP2004513127A5/ja
Application granted granted Critical
Publication of JP4184785B2 publication Critical patent/JP4184785B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2002539348A 2000-10-31 2001-10-26 抗ヒスタミン薬及び抗アレルギー薬としてのインドリルピペリジン誘導体 Expired - Fee Related JP4184785B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200002615A ES2172436B1 (es) 2000-10-31 2000-10-31 Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
PCT/EP2001/012450 WO2002036589A1 (en) 2000-10-31 2001-10-26 Indolylpiperidine derivatives as antihistaminic and antiallergic agents

Publications (3)

Publication Number Publication Date
JP2004513127A JP2004513127A (ja) 2004-04-30
JP2004513127A5 JP2004513127A5 (US07816364-20101019-C00082.png) 2005-04-28
JP4184785B2 true JP4184785B2 (ja) 2008-11-19

Family

ID=8495472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002539348A Expired - Fee Related JP4184785B2 (ja) 2000-10-31 2001-10-26 抗ヒスタミン薬及び抗アレルギー薬としてのインドリルピペリジン誘導体

Country Status (16)

Country Link
US (1) US7189741B2 (US07816364-20101019-C00082.png)
EP (1) EP1330453B1 (US07816364-20101019-C00082.png)
JP (1) JP4184785B2 (US07816364-20101019-C00082.png)
AR (1) AR031168A1 (US07816364-20101019-C00082.png)
AT (1) ATE321761T1 (US07816364-20101019-C00082.png)
AU (1) AU2002223655A1 (US07816364-20101019-C00082.png)
CA (1) CA2427589A1 (US07816364-20101019-C00082.png)
DE (1) DE60118434T2 (US07816364-20101019-C00082.png)
DK (1) DK1330453T3 (US07816364-20101019-C00082.png)
ES (2) ES2172436B1 (US07816364-20101019-C00082.png)
MY (1) MY155914A (US07816364-20101019-C00082.png)
PE (1) PE20020543A1 (US07816364-20101019-C00082.png)
PT (1) PT1330453E (US07816364-20101019-C00082.png)
SI (1) SI1330453T1 (US07816364-20101019-C00082.png)
UY (1) UY27001A1 (US07816364-20101019-C00082.png)
WO (1) WO2002036589A1 (US07816364-20101019-C00082.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2201899B1 (es) * 2002-04-01 2005-06-01 Almirall Prodesfarma, S.A. Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos.
ES2201907B1 (es) * 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
JP4326468B2 (ja) * 2002-06-24 2009-09-09 シェーリング コーポレイション ヒスタミンh3アンタゴニストとして有用なインドール誘導体
WO2004047769A2 (en) * 2002-11-26 2004-06-10 Isis Pharmaceuticals, Inc. Benzimidazoles and analogs thereof as antibacterials
US20080015214A1 (en) * 2005-10-24 2008-01-17 Bignan Gilles C 3-piperidin-4-yl-indole orl-1 receptor modulators
JP5581055B2 (ja) * 2006-10-27 2014-08-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ピペリジル−プロパン−チオールccr3モジュレーター
PE20090188A1 (es) * 2007-03-15 2009-03-20 Novartis Ag Compuestos heterociclicos como moduladores de la senda de hedgehog
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK471479A (da) 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
US4742057A (en) * 1985-12-05 1988-05-03 Fujisawa Pharmaceutical Co., Ltd. Antiallergic thiazole compounds
US4843068A (en) 1985-12-27 1989-06-27 Nihon Nohyaku Co., Ltd. Pyrazole oxime derivatives and compositions
DK733788A (da) 1988-01-14 1989-07-15 Fujisawa Pharmaceutical Co Indolylpiperidinderivater og fremgangsmaade til fremstilling deraf
CA2129995C (en) * 1992-02-13 2000-04-11 Albert A. Carr Piperidinyl thiacyclic derivatives
JP3338913B2 (ja) * 1993-06-29 2002-10-28 大鵬薬品工業株式会社 テトラゾール誘導体
IT1271417B (it) 1993-10-15 1997-05-28 Erregierre Ind Chim Composti ad attivita' antiistaminica procedimento per la loro preperazione e composizioni farmaceutiche che li contengono.
DE19500689A1 (de) 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
DE19707628A1 (de) 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
AR013669A1 (es) 1997-10-07 2001-01-10 Smithkline Beecham Corp Compuestos y metodos
ES2165274B1 (es) 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AR028685A1 (es) 2000-06-14 2003-05-21 Lundbeck & Co As H Derivados de indol

Also Published As

Publication number Publication date
ES2172436B1 (es) 2004-01-16
DE60118434D1 (de) 2006-05-18
ATE321761T1 (de) 2006-04-15
DE60118434T2 (de) 2006-12-14
EP1330453A1 (en) 2003-07-30
AR031168A1 (es) 2003-09-10
PT1330453E (pt) 2006-07-31
CA2427589A1 (en) 2002-05-10
PE20020543A1 (es) 2002-07-17
ES2259052T3 (es) 2006-09-16
WO2002036589A1 (en) 2002-05-10
SI1330453T1 (sl) 2006-08-31
DK1330453T3 (da) 2006-08-07
UY27001A1 (es) 2001-12-28
US20040116471A1 (en) 2004-06-17
US7189741B2 (en) 2007-03-13
AU2002223655A1 (en) 2002-05-15
JP2004513127A (ja) 2004-04-30
EP1330453B1 (en) 2006-03-29
ES2172436A1 (es) 2002-09-16
MY155914A (en) 2015-12-15

Similar Documents

Publication Publication Date Title
JP4485353B2 (ja) 有効な抗ヒスタミン剤および抗アレルギー剤としての新規インドリルピペリジン誘導体
US5576321A (en) Compounds having effects on serotonin-related systems
US5614523A (en) Compounds having effects on serotonin-related systems
US5627196A (en) Compounds having effects on serotonin-related systems
US6172073B1 (en) Compounds having effects on serotonin-related systems
US5789402A (en) Compounds having effects on serotonin-related systems
JPH064587B2 (ja) 新規なインドール誘導体およびその酸付加塩ならびにそれらを含有する精神病治療剤
KR100683454B1 (ko) 항히스타민제 그리고 항알레르기제로서의 인돌일피페리딘유도체
CN1318416C (zh) 5-羟色胺能试剂吲唑酰胺化合物
TW200800194A (en) Kinase inhibitors
JP4184785B2 (ja) 抗ヒスタミン薬及び抗アレルギー薬としてのインドリルピペリジン誘導体
WO1994021627A1 (en) Indole derivatives as dopamine d4 antagonists
ES2265577T3 (es) Derivados de azaindolilpiperidina como agentes antihistaminicos y antialergicos.
JPS6257606B2 (US07816364-20101019-C00082.png)
JP2000080081A (ja) 1―〔(1―置換―4―ピペリジニル)メチル〕―4―ピペリジン誘導体及びそれを含有する医薬組成物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041025

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080723

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080805

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080904

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110912

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110912

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees